Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mohieldin M. Youssef"'
Autor:
Radwa A. Eladwy, Hatem A. Abdel-Aziz, Mohamed Fares, Sahar M. Abou-Seri, Mohieldin M. Youssef, Safinaz E. Abbas
Publikováno v:
European Journal of Medicinal Chemistry. 83:155-166
New series of 2-(2-arylidenehydrazinyl)pyrido[2,3-d]pyrimidines 5a–e and pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidines 6–15 were synthesized and evaluated for their cytotoxic activity against two cancer cell lines, namely PC-3 prostate cancer an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e46fc4369c765025b94df87314740b30
https://doi.org/10.1016/j.ejmech.2014.06.027
https://doi.org/10.1016/j.ejmech.2014.06.027
Publikováno v:
European journal of medicinal chemistry. 89
A novel series of N-substituted-4-phenylphthalazin-1-ones 14a-g bearing different anilines at the N-2 of phthalazin-1-one scaffold via acetyl-flexible linker was designed and synthesized for the development of potential anticancer agents. Compounds 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3edfd44bf70fc88c65387696561092b
https://pubmed.ncbi.nlm.nih.gov/25462265
https://pubmed.ncbi.nlm.nih.gov/25462265
Autor:
Amani E. Khalifa, Eman El-Ahwany, Andrew W. Liu, Mai F. Tolba, Noha N. Badawy, Ashraf B. Abdel-Naim, Mohieldin M. Youssef, Suher Zada
Publikováno v:
Scientific Reports
Sorafenib (SOR) is the first-line treatment for hepatocellular carcinoma (HCC). However, its use is hindered by the recently expressed safety concerns. One approach for reducing SOR toxicity is to use lower doses in combination with other less toxic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1d14689f877a1c581c2137577b8d522
http://id.nii.ac.jp/1394/00001440/
http://id.nii.ac.jp/1394/00001440/
Autor:
Sako H; Cell Signal Unit, Okinawa Institute of Science and Technology Graduate University (OIST), Okinawa, Japan., Youssef M; Cell Signal Unit, Okinawa Institute of Science and Technology Graduate University (OIST), Okinawa, Japan., Elisseeva O; Cell Signal Unit, Okinawa Institute of Science and Technology Graduate University (OIST), Okinawa, Japan., Akimoto T; Faculty of Sport Sciences, Waseda University, Saitama, Japan., Suzuki K; Faculty of Sport Sciences, Waseda University, Saitama, Japan., Ushida T; Department of Mechanical Engineering, The University of Tokyo, Tokyo, Japan., Yamamoto T; Cell Signal Unit, Okinawa Institute of Science and Technology Graduate University (OIST), Okinawa, Japan.
Publikováno v:
The EMBO journal [EMBO J] 2023 Sep 18; Vol. 42 (18), pp. e112469. Date of Electronic Publication: 2023 Jul 26.
Evidence of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis (ALS) Patients and Animal Models.
Autor:
Maksimovic K; Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada., Youssef M; Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada., You J; Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada., Sung HK; Translational Medicine Program, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.; Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada., Park J; Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada.
Publikováno v:
Biomolecules [Biomolecules] 2023 May 19; Vol. 13 (5). Date of Electronic Publication: 2023 May 19.